Page last updated: 2024-12-08

1,5-dihydro-fad

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

You're likely referring to **1,5-dihydroflavin adenine dinucleotide (1,5-dihydro-FAD)**.

**What is 1,5-dihydro-FAD?**

1,5-dihydro-FAD is a reduced form of the coenzyme flavin adenine dinucleotide (FAD). FAD is a critical cofactor for many enzymes, particularly those involved in redox reactions (reactions that involve electron transfer).

Here's a breakdown:

* **FAD:** In its oxidized form, FAD carries a positive charge. It can accept electrons from other molecules, becoming reduced.
* **1,5-dihydro-FAD:** The reduced form of FAD where it has gained two electrons and two protons. It becomes a neutral molecule.

**Why is 1,5-dihydro-FAD important for research?**

1,5-dihydro-FAD plays a vital role in research related to:

* **Enzymatic activity:** Studying the formation and role of 1,5-dihydro-FAD in enzymatic reactions provides insights into how enzymes function and catalyze reactions.
* **Redox processes:** Understanding the redox chemistry of FAD and its reduced form (1,5-dihydro-FAD) helps scientists unravel the mechanisms of various biological processes involving electron transfer, such as cellular respiration and photosynthesis.
* **Drug development:** Studying the interaction of 1,5-dihydro-FAD with enzymes is crucial for developing drugs targeting specific enzyme pathways, especially those related to diseases like cancer and neurological disorders.
* **Biochemistry and molecular biology:** 1,5-dihydro-FAD is a valuable tool for studying the structure and function of proteins, particularly those involved in electron transfer.

**In summary:** 1,5-dihydro-FAD is a key molecule in understanding the fundamental mechanisms of enzymatic reactions and redox processes. Its research applications are broad, spanning from basic biochemistry to drug development.

1,5-dihydro-FAD: chromophore component of E coli DNA photolyase [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID446013
CHEBI ID17877
SCHEMBL ID4363188
MeSH IDM0163851

Synonyms (35)

Synonym
flavin adenine dinucleotide (reduced)
adenosine 5'-(3-{d-ribo-5-[7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2h)-yl]-2,3,4-trihydroxypentyl} dihydrogen diphosphate)
CHEBI:17877
dihydroflavine-adenine dinucleotide
riboflavin 5'-(trihydrogen diphosphate), 1,5-dihydro-, p'-5'-ester with adenosine
adenosine 5-(trihydrogen pyrophosphate)
adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine (8ci)
FADH ,
dihydro-fad
riboflavin 5'-(trihydrogen diphosphate), 1,5-dihydro-, p'-5'-ester with adenosine (9ci)
1,5-dihydro-p-5-ester with adenosine
reduced flavine adenine dinucleotide
adenosine pyrophosphate, 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine (7ci)
1910-41-4
C01352
flavin adenine dinucleotide reduced
fadh2 ,
1,5-dihydro-fad
[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxo-1,5-dihydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] hydrogen phosphate
SCHEMBL4363188
{[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}[({[(2r,3s,4s)-5-{7,8-dimethyl-2,4-dioxo-1h,2h,3h,4h,5h,10h-benzo[g]pteridin-10-yl}-2,3,4-trihydroxypentyl]oxy}(hydroxy)phosphoryl)oxy]phosphinic acid
adenosine 5'-(trihydrogen pyrophosphate), 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine
adenosine 5'-{3-[d-ribo-5-(7,8-dimethyl-2,4-dioxo-1,2,3,4,5,10-tetrahydrobenzo[g]pteridin-10-yl)-2,3,4-trihydroxypentyl] dihydrogen diphosphate}
benzo[gr]pteridine riboflavin 5'-(trihydrogen diphosphate) deriv
adenosine pyrophosphate 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine
1,5-dihydro-riboflavin 5'-(trihydrogen diphosphate) p'->5'-ester with adenosine
adenosine pyrophosphate, 5'->5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine
adenosine 5'-(trihydrogen pyrophosphate), 5'->5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine
benzo[g]pteridine riboflavin 5'-(trihydrogen diphosphate) deriv
adenosine pyrophosphate, 5'-5'-ester with 5,10-dihydro-7,8-dimethyl-10-(d-ribo-2,3,4,5-tetrahydroxypentyl)alloxazine
[(2r,3s,4r,5r)-5-(6-amino-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl (2r,3s,4s)-5-(7,8-dimethyl-2,4-dioxo-1,3,4,5-tetrahydrobenzo[g]pteridin-10(2h)-yl)-2,3,4-trihydroxypentyl dihydrogen diphosphate (non-preferred name)
Q27102690
Q27113979
[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl [[(2r,3s,4s)-5-(7,8-dimethyl-2,
DTXSID301343006
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (2)

RoleDescription
Escherichia coli metaboliteAny bacterial metabolite produced during a metabolic reaction in Escherichia coli.
mouse metaboliteAny mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
flavin adenine dinucleotide
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (27)

PathwayProteinsCompounds
Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism4485
Citric Acid Cycle2127
Congenital Lactic Acidosis2127
Fumarase Deficiency2127
Mitochondrial Complex II Deficiency2127
2-Ketoglutarate Dehydrogenase Complex Deficiency2127
Pyruvate Dehydrogenase Deficiency (E3)2127
Pyruvate Dehydrogenase Deficiency (E2)2127
Warburg Effect4652
The Oncogenic Action of 2-Hydroxyglutarate2734
The Oncogenic Action of Succinate2933
The Oncogenic Action of Fumarate2934
Glutaminolysis and Cancer3536
The Oncogenic Action of L-2-Hydroxyglutarate in Hydroxyglutaric aciduria2835
The Oncogenic Action of D-2-Hydroxyglutarate in Hydroxyglutaric aciduria2936
Cytokinins Degradation113
LPS and Citrate Signaling and Inflammation2311
valine degradation I018
isoleucine degradation I018
Electron transport chain010
TCA cycle (Krebs cycle)3019
Catalytic cycle of mammalian FMOs07
Electron transport chain: OXPHOS system in mitochondria010
NAD+ metabolism014
Thermogenesis018
Cerebral organic acidurias, including diseases527
Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)08

Research

Studies (73)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (2.74)18.7374
1990's11 (15.07)18.2507
2000's29 (39.73)29.6817
2010's29 (39.73)24.3611
2020's2 (2.74)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.93

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.93 (24.57)
Research Supply Index4.32 (2.92)
Research Growth Index5.25 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.93)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews5 (6.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other69 (93.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]